Cigna Lifts 2026 Profit Floor To $30.60 A Share As Specialty Pharmacy Gains Offset A 22% Benefits Drop

Third-quarter adjusted earnings reached $7.98 a share, and the company announced a $3 billion modernization plan at its Investor Day.

Share
Cigna Lifts 2026 Profit Floor To $30.60 A Share As Specialty Pharmacy Gains Offset A 22% Benefits Drop

Cigna Group raised its 2026 outlook for adjusted earnings to at least $30.60 per share, up $0.15 from its prior projection, the company said Thursday in its third-quarter earnings release. Growth in specialty care and health insurance offset a 22% drop in pre-tax adjusted profit at its pharmacy benefit business.

Flat earnings, higher revenue

Cigna, a global health company that runs a pharmacy benefit business and sells health insurance, reported third-quarter adjusted income from operations of $2.1 billion, or $7.98 per share, against $7.83 a year earlier. Revenue rose 6% to $73.7 billion.

Shareholders' net income fell to $1.4 billion, or $5.47 per share, from $1.9 billion, or $6.98, a year earlier. The company said the drop mainly reflects the absence of an after-tax gain on a sale booked in the third quarter of 2025.

CEO Brian Evanko said the quarter shows how the company is "making health care more affordable and personalized."

Share repurchases totaled about $500 million for 1.8 million shares through November 4. The debt-to-capitalization ratio stood at 41.8% at September 30, against 44.9% a year earlier and 43.0% at the end of last year.

Pharmacy benefits slip, specialty climbs

Within Evernorth, the segment that manages drug benefits and specialty pharmacy, pre-tax adjusted profit from pharmacy benefit services fell 22% to $765 million from $975 million. The company blamed large client contract renewals and strategic investments, which it said matched earlier commentary. Revenue in that business rose 9%, mainly on drug mix.

Specialty and Care Services profit rose 15% to $1.064 billion, which the company tied to strong organic growth, including greater use of biosimilars and specialty generics. Revenue there rose 1%.

Cigna Healthcare's pre-tax adjusted profit rose 15% to $1.193 billion, helped by higher investment income and better operating efficiency. Its medical care ratio, the share of premiums spent on medical costs, was 85.0%, against 84.8% a year earlier.

Outlook, Investor Day and shrinking customer counts

Cigna Healthcare's full-year profit floor rose $50 million to at least $4.6 billion. Its medical care ratio forecast was narrowed by 50 basis points to 84.2%, plus or minus 25 basis points. Evernorth's floor is at least $6.9 billion.

At its Investor Day, the company set long-term targets of 10%-14% annual growth in adjusted earnings per share and about $50 billion in cumulative operating cash flow through 2030. It also announced "Accelerate to One," a multi-year, $3 billion modernization and productivity initiative.

Total customer relationships fell 6% from the end of December to 177.6 million. Pharmacy customers fell 5% to 117.7 million, which the company tied to expected client transitions and lower health plan membership. Behavioral customers fell 19% after a government contract ended, with minimal impact on revenue and profit, the company said. In April, Cigna announced it will exit the Individual and Family Plans medical business as of January 1, 2027.

Management was scheduled to discuss the results and outlook on a call at 8:30 a.m. ET Thursday.

Sources

More on Cigna Group

All Cigna Group (CI) coverage →